The utilization of interim positron emission tomography (PET) imaging to guide therapeutic decisions has the potential to further individualize therapy, avoid unnecessary treatment and associated toxicity, and optimize outcomes for patients with Hodgkin lymphoma (HL). In this activity, participants will learn about the different PET-adapted strategies being investigated in HL, with a focus on the interpretation of data for the practical use of interim PET, to help providers evaluate the current clinical evidence and applicability to their practice.
Practical Application of PET-Adapted Therapy in Hodgkin Lymphoma
